Development of a live topical microbicide for women
Retrovirology volume 3, Article number: S37 (2006)
Osel is developing a live microbicide, employing H2O2-producing Lactobacillus jensenii 1153, a natural component of human vaginal microflora, as a delivery vehicle.
Materials and methods
An expression cassette harboring native regulatory elements was optimized to secrete high levels of modified cyanovirin-N (P51G) (CV-N). The expression cassette was stably integrated into the bacterial chromosome.
The CV-N-producing L. jensenii retained important characteristics of the native bacterial phenotype and secreted high levels of full-length CV-N that completely inhibited the infectivity of CCR5-tropic HIVBaL in vitro, with an IC50 near 1 nM. We further demonstrated that this strain was capable of association with epithelial cells in the vaginal lumen of CD-1 mice, and expressed CV-N in vivo in this model and when cultured in cervicovaginal lavage fluid of pigtailed macaques. We are evaluating potential regulatory issues, bacterial formulations, vaginal colonization, in situ CV-N expression, and host immunological responses in non-human primate models.
This work represents a major step towards the development of a simple, cost-effective, female-controlled preventative against heterosexual transmission of HIV.
Supported by NIH grants U19 AI60615 and U01 AI066708.
About this article
Cite this article
Xu, Q., Lagenaur, L., Liu, X. et al. Development of a live topical microbicide for women. Retrovirology 3 (Suppl 1), S37 (2006). https://doi.org/10.1186/1742-4690-3-S1-S37